ESC 365 - Safety and quality of life assessment at 6 months follow-up of the valvosoft pivotal study.

ESC Professional Premium Access

Safety and quality of life assessment at 6 months follow-up of the valvosoft pivotal study.

Session: TAVI vs. SAVR: still unresolved question?

Topic: Aortic Valve Intervention

Speaker: Doctor M. van Wely (Nijmegen, NL)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Marleen van Wely

University Hospital Nijmegen, Nijmegen (Netherlands (The))

0 follower

5 more presentations in this session

Transcatheter versus surgical aortic valve replacement in lower-risk patients: an updated meta-analysis of randomised controlled trials

Speaker: Doctor R. Reddy (London, GB)

Incidence of aortic valve reintervention in patients with aortic stenosis undergoing TAVI vs SAVR: A systematic review and meta-analysis of randomised controlled trials

Speaker: Miss J. Groberio (Vitoria, BR)

Transcatheter versus surgical aortic valve replacement in aortic stenosis patients requiring mechanical circulation support: a nationwide Japanese study

Speaker: Doctor K. Mitsui (Suita, JP)

Transcatheter aortic valve implantation in failed bioprosthetic or native valves: a systematic review and meta analysis

Speaker: Doctor R. Kaddoura (Doha, QA)

Unlocking the future: machine learning models for predicting in-hospital mortality after transcatheter aortic valve replacement: a single-arm meta-analysis

Speaker: Doctor H. Ahmed (Omaha, US)

Access the full session

TAVI vs. SAVR: still unresolved question?

Speakers: Doctor M. van Wely, Doctor R. Reddy, Miss J. Groberio, Doctor K. Mitsui, Doctor R. Kaddoura...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources